** Shares of calibration service provider Transcat TRNS.O down as much as 8.5% to $79.19
** Brokerage Oppenheimer downgrades stock to "perform" from "outperform", removes PT
** Company posted Q3 results below expectations and lowered FY25 organic service growth forecast after market close on Monday, sending shares down as much as 24.2% on Tuesday
** Brokerage cites weaker forecast, reduced growth and margin improvement expectations, and impaired management credibility behind downgrade
** Says investors lost confidence in the company's growth stability, even as the company expects to return to historical growth rates in FY26, as reduced forecast implies organic service revenue decline in present quarter
** Three of five brokerages rate the stock "buy", two "hold"; with a median PT of $106, according to data compiled by LSEG
** TRNS fell ~3% in 2024
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。